These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5923766)

  • 1. Renal toxicity following oral cholecystography with oragrafin (ipodate calcium).
    Harrow BR; Winslow OP
    Radiology; 1966 Oct; 87(4):721-4. PubMed ID: 5923766
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholecystography and renal failure.
    Daymond TJ
    Lancet; 1971 Sep; 2(7723):549-50. PubMed ID: 4105699
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical comparison of locetamic acid (cholebrine) and ipodate sodium (Orgrafin).
    Neal RR; Harvey KG; Cantwell KG; Press HC
    AJR Am J Roentgenol; 1979 May; 132(5):735-6. PubMed ID: 155391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal cholecystography.
    Sargent EN; Guth PH; Graffman M
    Radiology; 1967 May; 88(5):997-1001. PubMed ID: 6025059
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind study of ipodate and the non-diagnostic cholecystogram.
    Newman DE; Fellows KE
    J Can Assoc Radiol; 1970 Sep; 21(3):149-52. PubMed ID: 4920246
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of calcium Oragrafin granules in repeat cholecystography, with supplemental ultrasonographic evaluation.
    Fiske SA; Stamper DW
    J Am Osteopath Assoc; 1984 Mar; 83(7):512-5. PubMed ID: 6706718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems related to the radiographic study of the biliary tract using oral or intravenous contrast media. Main side effects and biochemical changes induced by the administration of contrast media].
    Limido G
    Minerva Dietol Gastroenterol; 1984; 30(1):9-15. PubMed ID: 6374500
    [No Abstract]   [Full Text] [Related]  

  • 8. The reliability of cholecystography with calcium ipodate augmentation.
    Seymour EQ
    Am Surg; 1980 Jun; 46(6):352-4. PubMed ID: 6772057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACUTE RENAL FAILURE FOLLOWING ORAL CHOLECYSTOGRAPHY.
    TEPLICK JG; MYERSON RM; SANEN FJ
    Acta Radiol Diagn (Stockh); 1965 Jul; 3():353-69. PubMed ID: 14328214
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholecystography and renal failure.
    Lancet; 1971 Jul; 2(7716):146-7. PubMed ID: 4104470
    [No Abstract]   [Full Text] [Related]  

  • 11. ORAGRAFIN AS A SUPPLEMENTAL CONTRAST AGENT IN ORAL CHOLECYSTOGRAPHY.
    RICHARDSON GA; SCHREIBER MH
    Tex State J Med; 1963 Aug; 59():788-9. PubMed ID: 14044597
    [No Abstract]   [Full Text] [Related]  

  • 12. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations.
    Postlethwaite AE; Kelley WN
    Ann Intern Med; 1971 Jun; 74(6):845-52. PubMed ID: 5580635
    [No Abstract]   [Full Text] [Related]  

  • 13. Immediate repeat cholecystography with oragrafin-calcium after initial nonvisualization of the gallbladder.
    Pogonowska MJ; Collins LC
    Radiology; 1969 Jul; 93(1):179-81. PubMed ID: 5801136
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyropanoate cholecystography and reversible renal failure.
    Fisher MS
    JAMA; 1975 Nov; 234(7):743. PubMed ID: 1242457
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of diarrhea on gallbladder opacification during oral cholecystography: comparison of two cholecystographic agents (author's transl)].
    Fukuda K; Nanjo M; Harada J; Sekiya T; Kanehira Y; Anno I; Takayama M; Watanabe H; Yamada T; Yamaguchi M; Tada S
    Rinsho Hoshasen; 1979 Mar; 24(3):379-84. PubMed ID: 547079
    [No Abstract]   [Full Text] [Related]  

  • 16. Oragrafin, a new cholecystographic medium: a double-blind comparison with Telepaque.
    JUHL JH; COOPERMAN LR; CRUMMY AB
    Radiology; 1963 Jan; 80():87-91. PubMed ID: 13957983
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of iocetamic acid and sodium iopodate in cholecystography.
    Golberg B
    Radiol Clin (Basel); 1977; 46(1):42-9. PubMed ID: 136669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of three oral cholecystographic contrast media--iocetamic acid, iopanoic acid and sodium ipodate.
    Cargill A; Hately W
    Br J Radiol; 1981 Jan; 54(637):79-80. PubMed ID: 6449974
    [No Abstract]   [Full Text] [Related]  

  • 19. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.